ChemoCommunity

Characterizing chemoresponse communities at transcriptional and post-transcriptional levels.

Compound Details

The detailed records of NSC 691767 were elucidated in the following 4 sections: 1) Basis: basic information about NSC 691767; 2) Community: the network communities that were significantly associated with the response to NSC 691767; 3) Molecule: the relationships between components within communities and NSC 691767; 4) MDR: the compounds that were significantly associated with the NSC 691767.

NSC Compound Enrichment Correlation
NSC 253272 Acetamide, N-[(methylamino)carbonyl]-N-[[(methylamino)carbonyl]oxy]- (9CI) 0.00841144976667916 0.31490664
NSC 359466 Null 0.00841144976667916 0.31867685
NSC 736443 7-fluoro-2-(2-furoyl)-3-trifluoromethylquioxaline 1,4-dioxide 0.00841144976667919 0.39502548
NSC 745449 Null 0.00841144976667919 0.37821511
NSC 128571 Ethanesulfonic acid, compd. with 2-chloro-5-[4-[2-chloro-4-(4,6-diamino-2,2-dimethyl-s-triazin-1(2H)-yl)phenyl]butyl]benzenesulfonyl fluoride (1:1) (8CI) 0.00888636978630782 0.26681584
NSC 136468 Null 0.00888636978630782 0.20016274
NSC 169774 Bromocriptine methanesulfonate 0.00888636978630782 0.21928917
NSC 290193 CYCLOSPORIN A 0.00888636978630782 0.11866315
NSC 293046 Carbamimidothioic acid, (4-oxo-2-phenyl-4H-1-benzopyran-8-yl)methyl ester, monohydrobromide 0.00888636978630782 0.10343579
NSC 335766 Quinazoline, 4-ethyl-6-methoxy-7-(oxiranylmethoxy)- 0.00888636978630782 0.23534188
Total:137  Current:41    [First] [Prev] [Next] [Last]